The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (2) , 113-115
- https://doi.org/10.1038/sj.bmt.1703343
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 8 references indexed in Scilit:
- Inhaled Zanamivir for the Prevention of Influenza in FamiliesNew England Journal of Medicine, 2000
- Respiratory Distress Associated with ZanamivirNew England Journal of Medicine, 2000
- The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantationBone Marrow Transplantation, 1999
- Infections in adults undergoing unrelated donor bone marrow transplantationBritish Journal of Haematology, 1999
- Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B VirusThe Journal of Infectious Diseases, 1998
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 YearsAnnals of Internal Medicine, 1993